duloxetine hydrochloride has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asama, H; Hashimoto, M; Hikichi, T; Irie, H; Kato, T; Kobashi, R; Konno, N; Nakamura, J; Ohira, H; Okubo, Y; Sato, Y; Sugimoto, M; Suzuki, R; Takagi, T; Takasumi, M | 1 |
| Hao, H; Ichimaru, Y; Ijichi, H; Ishii, Y; Kajiwara, I; Kim, J; Kitajima, O; Masamune, A; Oshima, Y; Sano, M; Suzuki, T | 1 |
1 review(s) available for duloxetine hydrochloride and Pancreatic Neoplasms
| Article | Year |
|---|---|
Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Topics: Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Peripheral Nervous System Diseases; Pregabalin; Randomized Controlled Trials as Topic | 2022 |
1 other study(ies) available for duloxetine hydrochloride and Pancreatic Neoplasms
| Article | Year |
|---|---|
Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline pathway and its antitumor effects.
Topics: Animals; Cancer Pain; Duloxetine Hydrochloride; Humans; Mice; Norepinephrine; Pancreatic Neoplasms; Quality of Life | 2020 |